Navigation Links
Plato BioPharma, Inc Appoints New Board Member

WESTMINSTER, Colo., Feb. 10, 2011 /PRNewswire/ -- Plato BioPharma, Inc ("PBI") announced today that its Board of Directors has appointed a new director, Mr. Dan Mitchell, effective November 1, 2010.  Dan has been in the venture capital industry for over 25 years focused on early stage opportunities primarily in healthcare and biotech industries.  Dan also serves on the Boards of Directors of Kalypto Medican, GlobeImmune, and Apoplogic.

"Dan is an outstanding addition to the Plato BioPharma Board," said Craig F. Plato, CEO and founder of Plato BioPharma. "His substantial experience and financial background will serve both our shareholders and customers well as PBI continues to grow and expand its capabilities and offerings."

Dan began his venture career at the First National Bank of Chicago's Institutional Venture Capital Fund, and then co-founded Capital Health Venture Partners, a healthcare-focused venture fund in 1985.  In 1996 he co-founded Sequel Venture Partners ("Sequel"). Sequel invests in seed and early stage opportunities primarily in the Front Range of Colorado.  His prior investments include Pyxis (acq. by Cardinal Health), Genomic Solutions (acq. by Harvard Bioscience), Tetra Technologies, Quovadx, and Myogen (acq. by Gilead Sciences, Inc).

Founded in 2009, Plato BioPharma, Inc is a leading preclinical contract research organization (CRO).  The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas.  PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker, and histological analyses.  The company specializes in custom study design and execution engagements ranging from pharmacokinetics through disease model and proof-of-concept evaluation.  PBI is headquartered in Westminster, Colorado.

Bob Leahy 1-303-506-6960

SOURCE Plato BioPharma, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
3. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
4. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
5. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
6. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
7. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
8. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
9. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
10. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
11. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015  AccuTEC Blades, ... a new corporate logo and brand identity program. ... design and engineering of bladed products where "the ... --> --> Serving manufacturers and ... and auto glass equipment, AccuTEC,s product lines include ...
(Date:12/1/2015)... of adjunctive metformin therapy does not improve glycemic outcomes in ... from T1D Exchange and funded by the ... measures of obesity, including weight and BMI. The results, published ... American Medical Association , are from the largest clinical trial ... obese adolescents with type 1 diabetes. recent ...
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: ... enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting through ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... SACC-GA and SACC-USA through membership and leadership since 2008. Gary Bruce, President ... SACC-USA . Gary has spent a significant amount of time in Sweden ...
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare Medical ... HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes annually ... propose exciting enhancements to the medical landscape. , The UCLH team won the ...
(Date:11/30/2015)... ... 2015 , ... Trevor and Taylor Crabb have unveiled an exciting new ... represent the United States. This hybrid crowdfunding campaign is designed to provide ... in addition to offering corporate sponsors with some great marketing deliverables with the brothers ...
Breaking Medicine News(10 mins):